Compare Cytokinetics Inc (CYTK) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Tyson Foods, Inc. — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Tyson Foods, Inc. trades at $56.25 (market cap $19.85B). The key difference: Tyson Foods, Inc. is the larger of the two by market cap, and Tyson Foods, Inc. pays a 3.62% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | TSN | |
|---|---|---|
Market Cap | $10.63B | $19.85B |
Sector | Technology | Consumer Staples |
52-Week High | $87.26 | $68.75 |
52-Week Low | $34.31 | $50.72 |
Enterprise Value | $10.74B | $27.12B |
Dividend Yield | — | 3.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
